← Leaderboards
Mary Jane Potash
St. Luke'S-Roosevelt Inst For Hlth Scis
$12,977,842
Attributed
$17,788,435
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$17,788,435 · 12
By mechanism
R01$13,764,118 · 5
R21$1,593,077 · 4
R33$1,169,100 · 1
P01$1,092,640 · 1
R03$169,500 · 1
Top collaborators
- David J Volsky19 shared
Most similar at St. Luke'S-Roosevelt Inst For Hlth Scis
Same institution · by research overlap
- David J Volsky$39,337,604
- Jennifer L Kelschenbach$2,364,977
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageBrainCellsVirusInfectionResponseBaseRouteChronicBrain DiseasesVirus DiseasesHiv-1Animal ModelVirus ReplicationProteinsInflammatoryImmune ResponseHiv InfectionsRelative (Related Person)ImmunocompetentPreventAntiretroviral TherapyDefectAntiviral Agents
Grant awards (49)
Functional Cure of HIV Neurocognitive Disease by Induction of Innate Immunity$211,250
R21 · FY2023 · NS · contact PI
Functional Cure of HIV Neurocognitive Disease by Induction of Innate Immunity$253,500
R21 · FY2022 · NS · contact PI
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2020 · NS · contact PI
Reversal of HIV Cognitive Disease in Mice Employing Broadly Specific T Cell Vaccines$84,750
R03 · FY2020 · NS · contact PI
Toward control of HIV neuropathogenesis by innate immunity$706,571
R01 · FY2019 · NS · contact PI
Reversal of HIV Cognitive Disease in Mice Employing Broadly Specific T Cell Vaccines$84,750
R03 · FY2019 · NS · contact PI
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2018 · NS · contact PI
Toward control of HIV neuropathogenesis by innate immunity$706,571
R01 · FY2017 · NS · contact PI
Toward control of HIV neuropathogenesis by innate immunity$716,741
R01 · FY2016 · NS · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$661,947
R01 · FY2015 · DA
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$624,490
R01 · FY2014 · DA
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$634,314
R01 · FY2013 · DA
HIV sexual transmission in mice:study of microbicide efficacy$380,364
R33 · FY2013 · AI · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$98,594
R01 · FY2013 · DA
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$662,163
R01 · FY2012 · DA
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$469,674
R01 · FY2012 · MH
HIV sexual transmission in mice:study of microbicide efficacy$398,218
R33 · FY2012 · AI · contact PI
Toward a Mouse Model of HIV-1 Infection and Drug Addiction$599,908
R01 · FY2011 · DA
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$471,010
R01 · FY2011 · MH
HIV sexual transmission in mice:study of microbicide efficacy$390,518
R33 · FY2011 · AI · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$477,160
R01 · FY2010 · MH
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$227,841
R01 · FY2010 · MH
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$479,594
R01 · FY2009 · MH
HIV sexual transmission in mice:study of microbicide efficacy$217,425
R21 · FY2009 · AI · contact PI
Markers of HIV Brain Disease under HAART: Validation in a Mouse Model$481,627
R01 · FY2008 · MH
Macrophage model of the sanctuary of HIV in the brain$353,897
R01 · FY2008 · NS · contact PI
HIV sexual transmission in mice:study of microbicide efficacy$213,556
R21 · FY2008 · AI · contact PI
Macrophage model of the sanctuary of HIV in the brain$353,897
R01 · FY2007 · NS · contact PI
Core--Virology/Cell Genetics$221,621
P01 · FY2007 · NS · contact PI
Mode of virus transmission into the brain in a mouse model of HIV-infecion$211,571
R21 · FY2007 · NS · contact PI
Macrophage model of the sanctuary of HIV in the brain$364,467
R01 · FY2006 · NS · contact PI
HIV-1 in macrophages: Role in AID's Dementia$317,474
R01 · FY2006 · NS · contact PI
Core--Virology/Cell Genetics$225,083
P01 · FY2006 · NS · contact PI
Mode of virus transmission into the brain in a mouse model of HIV-infecion$181,575
R21 · FY2006 · NS · contact PI
Macrophage model of the sanctuary of HIV in the brain$373,238
R01 · FY2005 · NS
HIV-1 in macrophages: Role in AID's Dementia$325,114
R01 · FY2005 · NS
Core--Virology/Cell Genetics$218,565
P01 · FY2005 · NS
HIV-1 in macrophages: Role in AID's Dementia$325,114
R01 · FY2004 · NS
Core--Virology/Cell Genetics$212,497
P01 · FY2004 · NS
HIV-1 in macrophages: Role in AID's Dementia$358,633
R01 · FY2003 · NS
MACROPHAGE MODEL OF THE SANCTUARY OF HIV-1 IN THE BRAIN$294,156
R01 · FY2003 · NS
Core--Virology/Cell Genetics$214,874
P01 · FY2003 · NS
HIV-1 in macrophages: Role in AID's Dementia$361,238
R01 · FY2002 · NS
MACROPHAGE MODEL OF THE SANCTUARY OF HIV-1 IN THE BRAIN$286,117
R01 · FY2002 · NS
HIV pathogenesis in a model of human brain development$152,100
R21 · FY2002 · NS
MACROPHAGE MODEL OF THE SANCTUARY OF HIV-1 IN THE BRAIN$278,331
R01 · FY2001 · NS
HIV pathogenesis in a model of human brain development$152,100
R21 · FY2001 · NS
MACROPHAGE MODEL OF THE SANCTUARY OF HIV-1 IN THE BRAIN$50,000
R01 · FY2001 · NS
MACROPHAGE MODEL OF THE SANCTUARY OF HIV-1 IN THE BRAIN$270,755
R01 · FY2000 · NS